 |
| Introduction |  Top |
|
 |
|
The future belongs to the bioentrepreneur p1
Stephen M. Edgington
doi:10.1038/5387
PDF
(68K)
|
|
| Bioentrepreneur | Top |
|
|
|
Bioentrepreneurship around the world pp3 - 4
Aris Persidis
doi:10.1038/5388
Abstract + references | PDF
(137K)
|
|
|
|
Growing an international biotechnology company p5
Pascal Brandys
doi:10.1038/5394
Abstract | PDF
(49K)
|
|
|
|
Europe discovers bioentrepreneurship p6
Paul Haycock
doi:10.1038/5395
Abstract + references | PDF
(54K)
|
|
|
|
Some thoughts on bioentrepreneurship pp7 - 8
Alan Walton
doi:10.1038/5396
Abstract | PDF
(61K)
|
|
|
|
Factors for success in biotechnology: Then and now pp9 - 10
Steven Gillis
doi:10.1038/5397
Abstract | PDF
(58K)
|
|
|
|
Five "C's" of successful startups pp11 - 12
James C. Blair
doi:10.1038/5398
Abstract | PDF
(61K)
|
|
|
|
The three pillars of bioentrepreneurship pp13 - 15
Hubert J. P. Schoemaker
& Anne Faulkner Schoemaker
doi:10.1038/5399
Abstract + references | PDF
(81K)
|
|
|
|
Business models for the bioentrepreneur p16
Jean−François Formela
doi:10.1038/5400
Abstract + references | PDF
(51K)
|
|
|
|
Venturing into drug discovery p17
Michael Steinmetz
doi:10.1038/5401
Abstract + references | PDF
(50K)
|
|
|
|
A bill of rights for bioentrepreneurs p18
Carl B. Feldbaum
doi:10.1038/5402
Abstract | PDF
(47K)
|
|
| Strategic Planning | Top |
|
|
|
Molecular medicine and information−based targeted healthcare pp19 - 21
George Poste
doi:10.1038/5403
Abstract | PDF
(103K)
|
|
|
|
Biotechnology's metamorphosis into a drug discovery industry pp22 - 24
Jürgen Drews
doi:10.1038/5405
Abstract + references | PDF
(73K)
|
|
|
|
The power of genomics to transform the biotechnology industry pp25 - 27
William A. Haseltine
doi:10.1038/5408
Abstract + references | PDF
(86K)
|
|
|
|
Optimizing the impact of genomics on drug discovery and development pp29 - 30
Stanley T. Crooke
doi:10.1038/5409
Abstract | PDF
(57K)
|
|
|
|
The evolving role of collaboration in biotechnology pp31 - 32
James M. Gower
doi:10.1038/5411
Abstract + references | PDF
(62K)
|
|
|
|
In silico drug discovery: Tools for bridging the NCE gap pp33 - 34
Bruno L. Larvol
& L. John Wilkerson
doi:10.1038/5412
Abstract + references | PDF
(91K)
|
|
|
|
Cementing links between industry and the university pp35 - 36
Richard Jennings
doi:10.1038/5414
Abstract + references | PDF
(62K)
|
|
| Management | Top |
|
|
|
Becoming a bioentrepreneur pp37 - 38
Hugh Young Rienhoff Jr.
doi:10.1038/5415
Abstract | PDF
(73K)
|
|
|
|
The startup balancing act: Hiring the right talent pp39 - 40
Simon Moroney
doi:10.1038/5416
Abstract | PDF
(58K)
|
|
|
|
Building the board of directors pp41 - 42
Jeremy Curnock Cook
& Geoffrey Vernon
doi:10.1038/5417
Abstract | PDF
(59K)
|
|
|
|
Scenes from an unlikely marriage: Building a corporate culture in biotechnology pp43 - 44
Christopher S. Henney
doi:10.1038/5419
Abstract | PDF
(154K)
|
|
|
|
For success, focus your strengths pp45 - 46
Arthur D. Levinson
doi:10.1038/5420
Abstract | PDF
(57K)
|
|
|
|
The patenting challenges of gene discovery p47
Eugene Moroz
& Dorothy R. Auth
doi:10.1038/5421
Abstract + references | PDF
(56K)
|
|
|
|
Making your genes come true pp48 - 49
Eric Tomlinson
doi:10.1038/5422
Abstract | PDF
(74K)
|
|
| Finance | Top |
|
|
|
Navigating biotechnology's new fiscal opportunities pp51 - 53
Dennis J. Purcell
doi:10.1038/5423
Abstract | PDF
(105K)
|
|
|
|
Snaring a venture capital investment p54
Michael Lytton
doi:10.1038/5430
Abstract | PDF
(49K)
|
|
|
|
Quantifying the dream: Valuation approaches in biotechnology pp55 - 56
Stelios Papadopoulos
doi:10.1038/5431
Abstract | PDF
(58K)
|
|
|
|
When to access the capital markets pp57 - 58
Garry E. Menzel
doi:10.1038/5432
Abstract | PDF
(135K)
|
|
|
|
How do you measure "success" in a biotechnology company? pp59 - 60
Elizabeth M. Greetham
doi:10.1038/5435
Abstract | PDF
(60K)
|
|
|
|
Biotechnology mergers and acquisitions pp61 - 62
Farah H. Champsi
doi:10.1038/5436
Abstract | PDF
(59K)
|
|
|
|
Where have all the investors gone?: The case for consolidation p63
Robert S. Esposito
& Marc J. Ostro
doi:10.1038/5437
Abstract | PDF
(50K)
|
|
|
|
Public sector funding in the UK p64
David A. A. Owen
doi:10.1038/5438
Abstract | PDF
(51K)
|
|
|
Top |
|
|
